Approaches for optimal drug development and clinical trial design for breast cancer brain metastasis.
Publication
, Journal Article
Siegel, MB; Van Swearingen, AED; Anders, CK
Published in: Oncology (Williston Park, N.Y.)
July 2014
Duke Scholars
Published In
Oncology (Williston Park, N.Y.)
ISSN
0890-9091
Publication Date
July 2014
Volume
28
Issue
7
Start / End Page
579 / 585
Related Subject Headings
- Humans
- Female
- Breast Neoplasms
- Brain Neoplasms
- Antineoplastic Combined Chemotherapy Protocols
Citation
APA
Chicago
ICMJE
MLA
NLM
Siegel, M. B., Van Swearingen, A. E. D., & Anders, C. K. (2014). Approaches for optimal drug development and clinical trial design for breast cancer brain metastasis. Oncology (Williston Park, N.Y.), 28(7), 579–585.
Siegel, Marni B., Amanda E. D. Van Swearingen, and Carey K. Anders. “Approaches for optimal drug development and clinical trial design for breast cancer brain metastasis.” Oncology (Williston Park, N.Y.) 28, no. 7 (July 2014): 579–85.
Siegel MB, Van Swearingen AED, Anders CK. Approaches for optimal drug development and clinical trial design for breast cancer brain metastasis. Oncology (Williston Park, NY). 2014 Jul;28(7):579–85.
Siegel, Marni B., et al. “Approaches for optimal drug development and clinical trial design for breast cancer brain metastasis.” Oncology (Williston Park, N.Y.), vol. 28, no. 7, July 2014, pp. 579–85.
Siegel MB, Van Swearingen AED, Anders CK. Approaches for optimal drug development and clinical trial design for breast cancer brain metastasis. Oncology (Williston Park, NY). 2014 Jul;28(7):579–585.
Published In
Oncology (Williston Park, N.Y.)
ISSN
0890-9091
Publication Date
July 2014
Volume
28
Issue
7
Start / End Page
579 / 585
Related Subject Headings
- Humans
- Female
- Breast Neoplasms
- Brain Neoplasms
- Antineoplastic Combined Chemotherapy Protocols